SavedAdd your journal

Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2014 / Cilt: 48 - Sayı: 2

Riskfactorsformucocutaneousfungalinfections in patients with type 2 diabetes mellitus

Tip 2 diyabetli hastalarda mukokutanöz fungal infeksiyonlar için risk faktörleri

Ahmet METİN
Gülşen AKOĞLU
Selma EMRE
Bekir ÇAKIR
Düriye Deniz DEMİRSEREN
Fatma Neslihan ÇUHADAR
Pages
87–91
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Frequency of male gender, diabetic nephropathy, neuropathy and retinopathy; DM durations and age of patients were all significantly higher in diabetic patients with fungal infections than in patients without fungal infections (all p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Mucocutaneous fungal infections are common in patients with diabetes mellitus (DM).
📊
Key Findings & Data:In this study, we aimed to determine the risk factors for mucocutaneous fungal infections in patients with Type 2 DM.
💡
Conclusion & Impact:Frequency of male gender, diabetic nephropathy, neuropathy and retinopathy; DM durations and age of patients were all significantly higher in diabetic patients with fungal infections than in patients without fungal infections (all p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Mucocutaneous fungal infections are common in patients with diabetes mellitus (DM). However, fungal infections do not develop in all patients with DM. In this study, we aimed to determine the risk factors for mucocutaneous fungal infections in patients with Type 2 DM. Materials and Methods: A total of 302 Type 2 DM patients with mucocutaneous fungal infections and 326 Type 2 DM patients without mucocutaneous fungal infections were enrolled. Demographic and clinical features, HbA1c levels, DM durations, body mass indexes (BMIs) and DM-related complications were compared between the groups and risk factors for developing mucocutaneous fungal infections were determined. Results: Of the 302 patients with mucocutaneous fungal infections, 81.2% (n=245) had dermatophytosis, 16.9% (n=51) had candida infections, and 2.0% (n=6) had pityriasis versicolor. Frequency of male gender, diabetic nephropathy, neuropathy and retinopathy; DM durations and age of patients were all significantly higher in diabetic patients with fungal infections than in patients without fungal infections (all p

Özet

Amaç: Diyabetes mellituslu (DM) hastalarda mukokutanöz fungal infeksiyonlar sık görülmektedir. Ancak diyabeti olan her hastada fungal infeksiyonlara rastlanmamaktadır. Bu çalışmada Tip 2 DM olan hastalarda görülen mukokutanöz fungal infeksiyonlarının araştırılması ve Tip 2 DM hastalarında fungal infeksiyonlar için risk faktörlerininin belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Çalışmaya mukokutanöz fungal infeksiyonu olan 302 Tip 2 DM hastası ve mukokutanöz fungal infeksiyonu olmayan 326 Tip 2 DM hastası dahil edildi. Hastaların demografik ve klinik özellikleri, HbA1c düzeyleri, DM süreleri, vücut kitle indeksleri (VKİ) ve DM ilişkili komplikasyonları karşılaştırıldı ve fungal infeksiyonların gelişmesi için risk faktörleri belirlendi. Bulgular: Mukokutanöz mantar hastalığı olan 302 hastanın %81,2sinde (n=245) dermatofit infeksiyonu, %16,9unda (n=51) kandidal infeksiyon, %2,0'ında (n=6) pitriyasis versikolor infeksiyonu saptandı. Fungal infeksiyonu olan diyabetik hastalarda erkek cinsiyet, yaş, diyabet süresi, diyabetik nefropati, nöropati ve retinopati varlığı fungal infeksiyonu olmayan diyabetik hastalara göre anlamlı olarak daha fazla idi (hepsi için p

🔖

Cite This Article

METİN, A., AKOĞLU, G., EMRE, S., ÇAKIR, B., DEMİRSEREN, D. D., ÇUHADAR, F. N. (2022). Riskfactorsformucocutaneousfungalinfections in patients with type 2 diabetes mellitus. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 48 - Sayı: 2, 87–91. https://ajindex.com/articles/621864

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Satman I, Yilmaz T, Şengül A, et al: Population-based study of diabetes and risk characteristics in Turkey.Results of the Turkish diabetes epidemiyology study (TURDEP). Diabetes Care 2002;25:1551-6.
  2. Terzi E, Peksarı Y: Diabetes mellitusun deri bulguları ve diyabetik ayak. Türkiye Klinikleri J Dermatol 2003;13:50-60.
  3. Şensoy G, Gençoğlan G: Tip II diyabetli hastalarda deri bulgularının vücut kitle indeks ve HBA1C ilişkisi. Anatol J Clin Investig 2009;3:213-7.
  4. Çiçek D, Kandi B, Oğuz S, ve ark: Diyabetes mellituslu hastalarda gözlenen deri bulguları. F.Ü. Sağ. Bil. Tıp Derg.2010;24:77-80.
  5. Hekimsoy Z, Toprak Ö, Bozdağ KE, Aslan S: Diyabetik hastalardaki deri bulguları. Türkiye Klinikleri J Dermatol 2002;12:181-4.
  6. Öztürkcan S, Topçu S, Özçelik S, Akıncı S: Diyabetes mellitusda deri bulguları. Türkiye Klinikleri J Dermatol 1993;3:53-6.
  7. Foss NT, Polon MH, Takada MH, Foss-Freitas MC, Foss MC: Skin lesions in diabetic patients. Rev Saude Publica 2005;39:677-82.
  8. Chang SJ, Hsu SC, Tien KJ, et al: Metabolic syndrome associated with toenail onycomycosis in Taiwanese with diabetes mellitus. Int J Dermatol 2008;47:467-72.
  9. Dogra S, Kumar B, Bhansali A, Chakrabarty A: Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002;41:647-51.
  10. Bristow IR, Spruce MC: Fungal foot infection, cellulitis and diabetes: a review. Diabetic Medicine 2009;26:548-51.
  11. Shahzad M, Robaee AA, Hani A, Alzolibani AA, Al Marshood AA, Al Moteri B: Skin Manifestations in Diabetic Patients Attending a Diabetic Clinic in the Qassim Region, Saudi Arabia. Med Princ Pract 2011;20:137-41.
  12. Romano C, Massai L, Asta F, Signorini M: Prevalence of dermatophytic and nail infections in diabetic patients. Mycoses 2001;44:83-6.
  13. Al- Mutairi N, Eassa BI, Al-Rqobah DA: Clinical and mycologic characteristics of onychomycosis in diabetic patients. Acta Dermatovenerol Croat 2010;18:84-91. Schaller M: Candida albicans - Interactions with the mucosa and the immune system. J Dtsch Dermatol Ges 2006;4:328-36. Abu-Elteen KH: Incidence and distribution of Candida species isolated from human skin in Jordan. Mycoses 1999;42:311-7.
  14. Al-Attas SA, Amro SO: Candidal colonization, strain diversity, and antifungal susceptibility among adult diabeticpatients. Ann Saudi Med 2010;30:101-8.
  15. Mayser P, Freund V, Budiharja D: Toenail onychomycosis in diabetic patients. Am J Clin Dermatol 2009;10:211-20.
  16. Gupta AK, Konnikov N, MacDonald P, et al: Prevalence and epidemiology of toenail onychomycosis in diabeti